{"slideshow_credits": null, "snippet": "The move will give shareholders a chance to hold a meeting on Dec. 18 to vote out a majority of the board and give Pershing Square and Valeant a green light on their $53 billion bid.", "abstract": "The move will give shareholders a chance to hold a meeting on Dec. 18 to vote out a majority of the board and give Pershing Square and Valeant a green light on their $53 billion bid.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/09/16/allergan-agrees-to-hold-meeting-that-could-lead-to-takeover/", "lead_paragraph": null, "headline": {"main": "Botox Maker Allergan Agrees to Hold Meeting That Could Lead to Takeover", "kicker": "DealBook"}, "_id": "5417c39338f0d851fd3a86dc", "word_count": "240", "multimedia": [{"height": 126, "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/08/23/business/dbpix-botox-1/dbpix-botox-1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-09-16T00:57:49Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": "2"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "3"}, {"name": "subject", "value": "Botox (Drug)", "rank": "1"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}